Advanced Glaucoma Clinical Trial
Official title:
Anterior Segment Optical Coherence Tomography Findings in Patients With Ahmed Glaucoma Drainage Implants With Either a Pericardial Patch Graft and Fibrin Tissue Glue or a Partial-Thickness Scleral Flap and Conventional Sutures
When implanting an Ahmed glaucoma tube, a scleral flap is usually created to cover the tube, and the conjunctiva is stitched back in place with nylon 10-0 sutures. It is hypothesized that an equally safe or better method is using a bovine pericardial patch graft that can be secured in place over the tube with tissue glue, and using tissue glue to reposition the conjunctiva in place.
Glaucoma drainage devices (GDD) are usually reserved for cases wherein filtration surgery
has failed, or for difficult cases that do not respond to filtration surgery, such as
neovascular or uveitic glaucoma.
The Ahmed Glaucoma drainage implant (New World Medical, Rancho, Cucamonga,CA) was introduced
to the market in 19942. It has a scarab-shaped end plate made of polypropylene (models S2,
S3 and B1) or silicone models (FP7, FP8 and FX1). Fenestrations have been added to the end
plate of the silicone models. Various sizes of the Ahmed drainage are available, including
those with a surface area of 96 mm2 (S3 and FP8) or 184 mm2 (S2 and FP7); while the
double-plate version has a surface area of 364mm2 (B1 and FX1). Aqueous humor passes from
the anterior chamber through two thin membrane-like elastomer sheets that theoretically
restrict flow until a pressure of greater than 8-12 mm Hg is exerted on them.
In the implantation of GDD, absorbable and non-absorbable sutures are used. Sutures are
typically used in securing the plate to the sclera, securing the tube to the sclera,
suturing a patch graft or scleral flap over the silicone tube, and for conjunctival closure.
Post-surgical course can be marked by discomfort, depending on the type of suture used.
Absorbable sutures can induce inflammation with localized surface and subconjunctival
fibrosis that leads to uneven conjunctival surface and excessive scarring. On the other
hand, non-absorbable sutures can erode through tissue post-operatively. Suturing the
conjunctiva can cause button-holes and tears, and can be the most time-intensive portion of
the surgery.
Fibrin glue has been used in various ophthalmic surgeries such as a sealant for perforated
and preperforated corneal ulcers, in mucous membrane grafts, in the management of
complicated hypotony and bleb leaks after trabeculectomy, and for preventing immediate
postoperative hypotony after glaucoma drainage implant surgery.
In a paper by Kahook and Noecker published in 2006, the authors did a retrospective
non-randomized case-control study that reviewed 28 cases of GDD implantations using
traditional suture materials compared to 14 consecutive cases of GDD implantation using
Tisseel fibrin glue (Baxter AG, Vienna, Austria) for closing the conjunctiva, securing the
pericardium patch graft and securing the tube to the sclera. The authors concluded that
Tisseel fibrin glue seems to be a safe substitute for some of the sutures used in GDD
surgery; and it has no impact on IOP control or complications. It appears to reduce
post-operative conjunctival inflammation and time of surgery.
Optical coherence tomography (OCT) is a high-resolution, non-invasive and reproducible
imaging technology that was primarily developed to evaluate the retina and retina nerve
fiber layer in patients with vitreo-retinal or optic nerve diseases11. Recently, the
anterior segment OCT (AS-OCT) has been developed and used to image anterior segment
structures. It has also been used to localize the Ex-PRESS miniature glaucoma implant in
porcine eyes, while the conventional OCT was used to show the anterior segment findings
after non-penetrating deep sclerectomy and the filtering blebs of eyes that underwent
glaucoma filtering surgery.
Patients scheduled for Ahmed Tube surgery, with or without lens extraction and intraocular
lens implant, will be recruited and randomized into two groups. The first group of patients
will have a pericardial patch graft covering the tube, and fibrin glue will be used to
attach the graft to the sclera and to close the conjunctiva. The second group will have a
partial- thickness scleral flap raised to cover the tube, and the conjunctiva will be closed
with conventional sutures.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04434612 -
Effect of OXSIGHT Smart Glasses on Patients With Advanced Glaucoma
|
N/A | |
Active, not recruiting |
NCT02173223 -
A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt
|
Phase 2 | |
Recruiting |
NCT00349414 -
Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma
|
Phase 1/Phase 2 |